These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22142967)

  • 61. Neutrophil activation in severe, early-onset COPD patients versus healthy non-smoker subjects in vitro: effects of antioxidant therapy.
    Milara J; Juan G; Peiró T; Serrano A; Cortijo J
    Respiration; 2012; 83(2):147-58. PubMed ID: 22094549
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human neutrophil oxidative bursts and their in vitro modulation by different N-acetylcysteine concentrations.
    Allegra L; Dal Sasso M; Bovio C; Massoni C; Fonti E; Braga PC
    Arzneimittelforschung; 2002; 52(9):669-76. PubMed ID: 12404881
    [TBL] [Abstract][Full Text] [Related]  

  • 63. N-acetylcysteine causes a transient stimulation of neutrophil migration.
    Elferink JG; de Koster BM
    Immunopharmacology; 1998 Jan; 38(3):229-36. PubMed ID: 9506822
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of free radical scavengers on histamine release from human basophils stimulated by immunological and non-immunological secretagogues.
    Gibbs BF; Wolff HH; Grabbe J
    Inflamm Res; 1999 Apr; 48 Suppl 1():S13-4. PubMed ID: 10350140
    [No Abstract]   [Full Text] [Related]  

  • 65. The effect of N-acetylcysteine on exercise-induced priming of human neutrophils. A chemiluminescence study.
    Huupponen MR; Mäkinen LH; Hyvönen PM; Sen CK; Rankinen T; Väisänen S; Rauramaa R
    Int J Sports Med; 1995 Aug; 16(6):399-403. PubMed ID: 7591392
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neutrophil-mediated lung damage: a new COPD phenotype?
    Sin D; van Eeden SF
    Respiration; 2012; 83(2):103-5. PubMed ID: 22142967
    [No Abstract]   [Full Text] [Related]  

  • 67. [Acetylcysteine in chronic obstructive pulmonary disease. Secretolytic, antioxidant or placebo?].
    Randerath W; Galetke W
    Med Monatsschr Pharm; 2003 Nov; 26(11):375-8. PubMed ID: 14652922
    [No Abstract]   [Full Text] [Related]  

  • 68.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 69.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.